Publications by authors named "C R Barraclough"

Can an interprofessionally designed and facilitated learning event change the way professionals understand each other's roles, enable them to better work with each other and improve patient care? Pharmacy and dental professionals are contractors to the NHS, providing services to the public. The way both professions are funded encourages them to generally work in isolation from the wider NHS, in contrast to other areas of healthcare and NHS systems. This study explores how working collaboratively at all stages of design, development, facilitation and engagement of a learning event impacts on the professionals taking part.

View Article and Find Full Text PDF

Background: As global life expectancy increases, older people with chronic diseases are being required to manage multiple and complex medicine regimes. However, polypharmacy raises the risk of medicine-related problems and preventable hospital admissions. To improve medicine use, English community pharmacies are commissioned to deliver Medicines Use Reviews (MURs), which are typically delivered from the pharmacy.

View Article and Find Full Text PDF

Objective: To present moxifloxacin as an alternative treatment option to ethambutol in an anti-tubercular therapy (ATT) regime in patients with presumed ocular tuberculosis (TB).

Methods: We identified all cases in our hospital referred for treatment of presumed ocular TB between 2009 and 2013. Age, gender, ophthalmic examination, blood tests, treatment regimens, adverse drug reactions, and outcomes were collected and analyzed for the patients who had moxifloxacin as part of their ATT.

View Article and Find Full Text PDF
Article Synopsis
  • A 36-year-old jewelry producer experienced symptoms including tremors, slurred speech, lethargy, and coordination issues, likely due to mercury exposure.
  • After treatment with 2,3-dimercapto-1-propanesulfonate, the patient showed significant clinical improvement and high levels of mercury excretion.
  • The report suggests that this treatment should be considered for patients with symptoms related to mercury vapor exposure and confirmed diagnosis.
View Article and Find Full Text PDF